Attributes | Values |
---|
rdf:type
| |
Description
| - Tumorové choroby jsou ve světe rozšíření a jejich léčba je intenzivně zkoumána. Úspěch léčby je závislí na mnoho faktorů jako je preventivní a citlivá diagnostika. V minulém desetiletí několik publikací dávalo expresi metalothioneinu do souvislosti s přítomností nádorového onemocnění jako je leukémie, nádor plic, vaječníků, pankreatu. V této práci uvádíme shrnutí výzkumu metalothioneinů v časné detekci a diagnostice tumorových markerů. (cs)
- A tumour disease or cancer, %22plague of the world%22, are words, which present a threat to humans as well as a subject of investigation for broaden scientific public. The success of treatment of the disease depends on many factors such as prevention, early and sensitive diagnostics. That means the sooner a cancer is detected, the better the chances to treat it successfully. In the last decade, several reports disclosed metallothioneins (MTs) expression as a useful prognostic factor for tumour progression and drug resistance in a variety of malignancies e.g. leukaemia, melanoma, breast, ovarian, renal, lung, pancreatic, gall bladder, esophageal, and basal cell carcinoma. The present work reports on investigation of involving of MTs in early detection of the disease as new tumour marker.
- A tumour disease or cancer, %22plague of the world%22, are words, which present a threat to humans as well as a subject of investigation for broaden scientific public. The success of treatment of the disease depends on many factors such as prevention, early and sensitive diagnostics. That means the sooner a cancer is detected, the better the chances to treat it successfully. In the last decade, several reports disclosed metallothioneins (MTs) expression as a useful prognostic factor for tumour progression and drug resistance in a variety of malignancies e.g. leukaemia, melanoma, breast, ovarian, renal, lung, pancreatic, gall bladder, esophageal, and basal cell carcinoma. The present work reports on investigation of involving of MTs in early detection of the disease as new tumour marker. (en)
|
Title
| - Association of formation and progression of a tumour disease and level of metallothioneins
- Spojení tvorby a progrese nádorového onemocnění s úrovní metalothioneinu (cs)
- Association of formation and progression of a tumour disease and level of metallothioneins (en)
|
skos:prefLabel
| - Association of formation and progression of a tumour disease and level of metallothioneins
- Spojení tvorby a progrese nádorového onemocnění s úrovní metalothioneinu (cs)
- Association of formation and progression of a tumour disease and level of metallothioneins (en)
|
skos:notation
| - RIV/62156489:43210/08:00121294!RIV09-AV0-43210___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/62156489:43210/08:00121294
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - metallothionein; tumour diseas (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/mistoVydani
| |
http://linked.open...i/riv/nazevZdroje
| - XII. pracovní setkání biochemiků a molekulárních biologů
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...iv/tvurceVysledku
| - Adam, Vojtěch
- Binková, Hana
- Eckschlager, Tomáš
- Hraběta, Jan
- Kizek, René
- Křížková, Soňa
- Průša, Richard
- Zítka, Ondřej
- Fabrik, Ivo
- Kukačka, Jiří
- Horaková, Zuzana
- Sýkorová, E.
|
number of pages
| |
http://purl.org/ne...btex#hasPublisher
| |
https://schema.org/isbn
| |
http://localhost/t...ganizacniJednotka
| |